KLK3 and prostate carcinoma: Fujita et al. showed that the ratio of serum fucosylated PSA could differentiate high-risk prostate cancer from biopsy-negative or high-risk prostate cancer using PhoSL to detect core-type fucosylated free PSA using a microcapillary electrophoresis-based immunoassay system [89].